4//SEC Filing
Spring Bank Pharmaceuticals, Inc. 4
Accession 0001209191-16-140920
CIK 0001566373operating
Filed
Sep 11, 8:00 PM ET
Accepted
Sep 12, 4:04 PM ET
Size
4.5 KB
Accession
0001209191-16-140920
Insider Transaction Report
Form 4
Afdhal Nezam H.
Chief Medical Officer
Transactions
- Purchase
Common Stock
2016-09-09$12.50/sh+2,400$30,000→ 40,150 total
Documents
Issuer
Spring Bank Pharmaceuticals, Inc.
CIK 0001566373
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001566373
Filing Metadata
- Form type
- 4
- Filed
- Sep 11, 8:00 PM ET
- Accepted
- Sep 12, 4:04 PM ET
- Size
- 4.5 KB